APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumococcal Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pneumococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032

27 December 2025105 pages

Choose your research edition.

Industry ResearchPneumococcal Polysaccharide Vaccine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Pneumococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumococcal Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pneumococcal Polysaccharide Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pneumococcal Polysaccharide Vaccine include Sino Biopharm, Zhifei Biological, Walvax, Merck & Co., Sinovac, Kangtai Bio, Antejin Biotechnology, AIM Bio and Sanofi Pasteur, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pneumococcal Polysaccharide Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pneumococcal Polysaccharide Vaccine market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pneumococcal Polysaccharide Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pneumococcal Polysaccharide Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pneumococcal Polysaccharide Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pneumococcal Polysaccharide Vaccine Market by Company

Sino Biopharm

Zhifei Biological

Walvax

Merck & Co.

Sinovac

Kangtai Bio

Antejin Biotechnology

AIM Bio

Sanofi Pasteur

Pfizer

Pneumococcal Polysaccharide Vaccine Segment by Type

PPSV23

PCV13

Others

Pneumococcal Polysaccharide Vaccine Segment by Application

Hospital

Centers for Disease Control and Prevention

Others

Pneumococcal Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pneumococcal Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PPSV23 Table 2. Major Company of PCV13 Table 3. Major Company of Others Table 4. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 6. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Pneumococcal Polysaccharide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (Units) Table 11. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Pneumococcal Polysaccharide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 16. North America Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 18. Europe Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 20. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 22. Latin America Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (Units) Table 24. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Pneumococcal Polysaccharide Vaccine Industry Trends Table 26. Pneumococcal Polysaccharide Vaccine Industry Drivers Table 27. Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges Table 28. Pneumococcal Polysaccharide Vaccine Industry Restraints Table 29. Global Pneumococcal Polysaccharide Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Pneumococcal Polysaccharide Vaccine Sales by Company (2021-2026) & (Units) Table 32. Global Pneumococcal Polysaccharide Vaccine Sales Share by Company (2021-2026) Table 33. Global Pneumococcal Polysaccharide Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Pneumococcal Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pneumococcal Polysaccharide Vaccine Major Company Production Sites and Headquarters Table 36. Global Pneumococcal Polysaccharide Vaccine Company, Product Type & Application Table 37. Global Pneumococcal Polysaccharide Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pneumococcal Polysaccharide Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (Units) Table 42. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Pneumococcal Polysaccharide Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (Units) Table 47. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Pneumococcal Polysaccharide Vaccine Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 53. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Pneumococcal Polysaccharide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (Units) Table 58. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Pneumococcal Polysaccharide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 63. North America Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 65. Europe Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 67. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 69. Latin America Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (Units) Table 71. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Sino Biopharm Company Information Table 73. Sino Biopharm Business Overview Table 74. Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolio Table 76. Sino Biopharm Recent Development Table 77. Zhifei Biological Company Information Table 78. Zhifei Biological Business Overview Table 79. Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolio Table 81. Zhifei Biological Recent Development Table 82. Walvax Company Information Table 83. Walvax Business Overview Table 84. Walvax Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Walvax Pneumococcal Polysaccharide Vaccine Product Portfolio Table 86. Walvax Recent Development Table 87. Merck & Co. Company Information Table 88. Merck & Co. Business Overview Table 89. Merck & Co. Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolio Table 91. Merck & Co. Recent Development Table 92. Sinovac Company Information Table 93. Sinovac Business Overview Table 94. Sinovac Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolio Table 96. Sinovac Recent Development Table 97. Kangtai Bio Company Information Table 98. Kangtai Bio Business Overview Table 99. Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolio Table 101. Kangtai Bio Recent Development Table 102. Antejin Biotechnology Company Information Table 103. Antejin Biotechnology Business Overview Table 104. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolio Table 106. Antejin Biotechnology Recent Development Table 107. AIM Bio Company Information Table 108. AIM Bio Business Overview Table 109. AIM Bio Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolio Table 111. AIM Bio Recent Development Table 112. Sanofi Pasteur Company Information Table 113. Sanofi Pasteur Business Overview Table 114. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio Table 116. Sanofi Pasteur Recent Development Table 117. Pfizer Company Information Table 118. Pfizer Business Overview Table 119. Pfizer Pneumococcal Polysaccharide Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolio Table 121. Pfizer Recent Development Table 122. North America Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 123. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 124. North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 125. North America Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 126. North America Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 127. North America Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 130. North America Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 132. Europe Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 133. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 134. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 135. Europe Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 136. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 140. Europe Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 144. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 146. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 150. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 152. Latin America Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 153. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 154. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 155. Latin America Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 156. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 160. Latin America Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (Units) Table 164. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (Units) Table 166. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 170. Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Pneumococcal Polysaccharide Vaccine Distributors List Table 175. Pneumococcal Polysaccharide Vaccine Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Pneumococcal Polysaccharide Vaccine Image Figure 2. Global Pneumococcal Polysaccharide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumococcal Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pneumococcal Polysaccharide Vaccine Sales (2021-2032) & (Units) Figure 5. PPSV23 Image Figure 6. Global PPSV23 Sales YoY Growth (2021-2032) & (Units) Figure 7. PCV13 Image Figure 8. Global PCV13 Sales YoY Growth (2021-2032) & (Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 11. Global Pneumococcal Polysaccharide Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pneumococcal Polysaccharide Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (Units) Figure 27. Centers for Disease Control and Prevention Image Figure 28. Global Centers for Disease Control and Prevention Sales YoY Growth (2021-2032) & (Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 31. Global Pneumococcal Polysaccharide Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pneumococcal Polysaccharide Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 44. North America Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. Europe Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Latin America Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 60. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pneumococcal Polysaccharide Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pneumococcal Polysaccharide Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • PPSV23
  • PCV13
  • Others
Applications
  • Hospital
  • Centers for Disease Control and Prevention
  • Others
Companies covered
  • Sino Biopharm
  • Zhifei Biological
  • Walvax
  • Merck & Co.
  • Sinovac
  • Kangtai Bio
  • Antejin Biotechnology
  • AIM Bio
  • Sanofi Pasteur
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pneumococcal Polysaccharide Vaccine Market by Type
  6. 1.3.1 PPSV23
  7. 1.3.2 PCV13
  8. 1.3.3 Others
  9. 1.4 Global Pneumococcal Polysaccharide Vaccine Market Size by Type
  10. 1.4.1 Global Pneumococcal Polysaccharide Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pneumococcal Polysaccharide Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pneumococcal Polysaccharide Vaccine Industry Trends
  2. 2.2 Pneumococcal Polysaccharide Vaccine Industry Drivers
  3. 2.3 Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Pneumococcal Polysaccharide Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pneumococcal Polysaccharide Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Pneumococcal Polysaccharide Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Pneumococcal Polysaccharide Vaccine Price (2021-2026)
  4. 3.4 Global Pneumococcal Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pneumococcal Polysaccharide Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Pneumococcal Polysaccharide Vaccine Company, Product Type & Application
  7. 3.7 Global Pneumococcal Polysaccharide Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pneumococcal Polysaccharide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pneumococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 Pneumococcal Polysaccharide Vaccine Regional Status and Outlook
  1. 4.1 Global Pneumococcal Polysaccharide Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pneumococcal Polysaccharide Vaccine Historic Market Size by Region
  3. 4.2.1 Global Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pneumococcal Polysaccharide Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pneumococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pneumococcal Polysaccharide Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pneumococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pneumococcal Polysaccharide Vaccine by Application
  1. 5.1 Pneumococcal Polysaccharide Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Centers for Disease Control and Prevention
  4. 5.1.3 Others
  5. 5.2 Global Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 5.2.1 Global Pneumococcal Polysaccharide Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pneumococcal Polysaccharide Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sino Biopharm
  2. 6.1.1 Sino Biopharm Company Information
  3. 6.1.2 Sino Biopharm Business Overview
  4. 6.1.3 Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolio
  6. 6.1.5 Sino Biopharm Recent Developments
  7. 6.2 Zhifei Biological
  8. 6.2.1 Zhifei Biological Company Information
  9. 6.2.2 Zhifei Biological Business Overview
  10. 6.2.3 Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolio
  12. 6.2.5 Zhifei Biological Recent Developments
  13. 6.3 Walvax
  14. 6.3.1 Walvax Company Information
  15. 6.3.2 Walvax Business Overview
  16. 6.3.3 Walvax Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Walvax Pneumococcal Polysaccharide Vaccine Product Portfolio
  18. 6.3.5 Walvax Recent Developments
  19. 6.4 Merck & Co.
  20. 6.4.1 Merck & Co. Company Information
  21. 6.4.2 Merck & Co. Business Overview
  22. 6.4.3 Merck & Co. Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolio
  24. 6.4.5 Merck & Co. Recent Developments
  25. 6.5 Sinovac
  26. 6.5.1 Sinovac Company Information
  27. 6.5.2 Sinovac Business Overview
  28. 6.5.3 Sinovac Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolio
  30. 6.5.5 Sinovac Recent Developments
  31. 6.6 Kangtai Bio
  32. 6.6.1 Kangtai Bio Company Information
  33. 6.6.2 Kangtai Bio Business Overview
  34. 6.6.3 Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
  36. 6.6.5 Kangtai Bio Recent Developments
  37. 6.7 Antejin Biotechnology
  38. 6.7.1 Antejin Biotechnology Company Information
  39. 6.7.2 Antejin Biotechnology Business Overview
  40. 6.7.3 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolio
  42. 6.7.5 Antejin Biotechnology Recent Developments
  43. 6.8 AIM Bio
  44. 6.8.1 AIM Bio Company Information
  45. 6.8.2 AIM Bio Business Overview
  46. 6.8.3 AIM Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
  48. 6.8.5 AIM Bio Recent Developments
  49. 6.9 Sanofi Pasteur
  50. 6.9.1 Sanofi Pasteur Company Information
  51. 6.9.2 Sanofi Pasteur Business Overview
  52. 6.9.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio
  54. 6.9.5 Sanofi Pasteur Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
7 North America by Country
  1. 7.1 North America Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 7.1.1 North America Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 7.2.1 North America Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 8.1.1 Europe Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 8.2.1 Europe Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 10.1.1 South America Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 10.2.1 South America Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pneumococcal Polysaccharide Vaccine Value Chain Analysis
  2. 12.1.1 Pneumococcal Polysaccharide Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pneumococcal Polysaccharide Vaccine Production Mode & Process
  7. 12.2 Pneumococcal Polysaccharide Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pneumococcal Polysaccharide Vaccine Distributors
  10. 12.2.3 Pneumococcal Polysaccharide Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst